High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
Saved in:
| Main Authors: | Elizabeth E. Powell, Gunter Hartel, Katharine M. Irvine, James O’Beirne, Vikas Bhasker, Patricia C. Valery |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Gastro Hep Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572324002036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)
by: Michelle J. Allen, et al.
Published: (2025-03-01) -
Alterations in neutrophil extracellular traps is associated with the degree of decompensation of liver cirrhosis
by: Juan M Agraz-Cibrian, et al.
Published: (2016-05-01) -
Prescribing Medications in Patients with Decompensated Liver Cirrhosis
by: Deepak N. Amarapurkar
Published: (2011-01-01) -
Treatment of Hepatitis B in Decompensated Liver Cirrhosis
by: Richard Guan, et al.
Published: (2011-01-01) -
Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01)